Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.57 |
| ▸ | CHAT | P28329 | 5/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.52 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4626594 | 1.00 | RXRA (0.57) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL29399914 | 1.00 | RXRA (0.57) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL27495890 | 0.98 | RXRA (0.55) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL27493524 | 0.98 | RXRA (0.55) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL27525379 | 0.98 | RXRA (0.55) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL10706700 | 0.90 | CHAT (0.62) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL10706694 | 0.90 | CHAT (0.62) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL10706687 | 0.90 | CHAT (0.62) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL10742158 | 0.89 | RXRA (0.53) | RXRACHATHDAC8HDAC6MTNR1A | |
| SCHEMBL10742163 | 0.89 | RXRA (0.53) | RXRACHATHDAC8HDAC6MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040132935-A1 | Branched crystalline polypropylene | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-07-08 | — | — | US | claimed |
| US-20040122191-A1 | Supercritical polymerization process and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC | 2004-06-24 | — | — | US | claimed |
| US-20040110910-A1 | High temperature bulk polymerization of branched crystalline polypropylene | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-06-10 | — | — | US | claimed |
| US-20040110909-A1 | Branched diene-modified crystalline polypropylene terpolymers | EXXONMOBIL CHEMICAL PATENTS, INC. | 2004-06-10 | — | — | US | claimed |
| US-20040110911-A1 | Diene-modified propylene copolymers | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-06-10 | — | — | US | claimed |
| WO-2004037871-A1 | BRANCHED CRYSTALLINE POLYPROPYLENE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-05-06 | — | — | WO | claimed |
| EP-1119575-B1 | BRIDGED METAL COMPLEXES | DOW CHEMICAL CO (US) | 2003-09-03 | — | — | EP | claimed |
| US-6500949-B2 | ALPHA-OLEFIN POLYMERIZATION CATALYST | DOW GLOBAL TECHNOLOGIES INC. | 2002-12-31 | — | — | US | claimed |
| US-20010025115-A1 | Bridged metal complexes | DOW GLOBAL TECHNOLOGIES LLC | 2001-09-27 | — | — | US | claimed |
| US-12503529-B2 | Polymers of 4-substituted hexadiene and processes for production thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-12466902-B2 | Non-coordinating anion type activators for use with polyolefin polymerization catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2025-11-11 | — | — | US | disclosed |
| EP-3941949-B1 | METHODS FOR IMPROVING GAS PHASE POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-3784648-B1 | NON-COORDINATING ANION TYPE ACTIVATORS CONTAINING CATION HAVING BRANCHED ALKYL GROUPS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2025-07-02 | — | — | EP | disclosed |
| US-12202917-B2 | Methods for improving gas phase polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-20010025115-A1 | Bridged metal complexes | DOW GLOBAL TECHNOLOGIES LLC | 2001-09-27 | — | — | US | disclosed |
| US-6284905-B1 | GROUP 4 TRANSITION METAL COMPLEX CONTAINING A BORON OR ALUMINUM BRIDGING GROUP CONTAINING A NITROGEN CONTAINING ELECTRON DONATING GROUP, ESPECIALLY AN AMIDO GROUP; OLEFIN SOLUTION OR SLURRY POLYMERIZATION CATALYSTS | THE DOW CHEMICAL COMPANY | 2001-09-04 | — | — | US | disclosed |
| EP-1119575-A1 | BRIDGED METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2001-08-01 | — | — | EP | disclosed |
| WO-2001046201-A1 | GALLIUM OR INDIUM-BRIDGED GROUP 4 METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |
| WO-2000020462-A2 | BRIDGED METAL COMPLEXES FOR GAS PHASE POLYMERIZATIONS | BP CHEMICALS LIMITED (GB) | 2000-04-13 | — | — | WO | disclosed |
| WO-2000020426-A1 | BRIDGED METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2000-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010025115-A1 | Bridged metal complexes | SLC39A14, NBAS, MCM4 | RXRA 3522/4885CHAT 4688/4885HDAC8 1358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.